StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.75−0.18 (-0.64%)

Close on Nov 17, 2026Market cap $1.81BP/E –Yield –

Zenas BioPharma total assets

Total assets on the balance sheet at the end of each period.

Zenas BioPharma's total assets was $675.22M at Sep 30, 2026. For fiscal 2025 it was $383.64M, up 3.7% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$383.64M+3.7%
FY2024Dec 31, 2024$369.97M+442.6%
FY2023Dec 31, 2023$68.18M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$675.22M+109.7%
Q2 FY2026Jun 30, 2026$701.69M+139.4%
Q1 FY2026Mar 31, 2026$747.68M+124.0%
Q4 FY2025Dec 31, 2025$383.64M+3.7%
Q3 FY2025Sep 30, 2025$322.02M-20.2%
Q2 FY2025Jun 30, 2025$293.09M+329.9%
Q1 FY2025Mar 31, 2025$333.77M–
Q4 FY2024Dec 31, 2024$369.97M–
Q3 FY2024Sep 30, 2024$403.43M–
Q4 FY2023Dec 31, 2023$68.18M–

More Zenas BioPharma figures

See a number that looks wrong?